Cargando…
Monoclonal Antibodies and Airway Diseases
Monoclonal antibodies, biologics, are a relatively new treatment option for severe chronic airway diseases, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS). In this review, we focus on the physiological and pathomechanisms of monoclonal antibodies, and we present recent study results reg...
Autores principales: | Lyly, Annina, Laulajainen-Hongisto, Anu, Gevaert, Philippe, Kauppi, Paula, Toppila-Salmi, Sanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763928/ https://www.ncbi.nlm.nih.gov/pubmed/33322143 http://dx.doi.org/10.3390/ijms21249477 |
Ejemplares similares
-
Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
por: Lyly, Annina, et al.
Publicado: (2021) -
Lung function and side effects of Aspirin desensitization: a real world study
por: Turpeinen, Heikki, et al.
Publicado: (2021) -
Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa
por: Laulajainen‐Hongisto, Anu, et al.
Publicado: (2020) -
Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases
por: Laulajainen-Hongisto, Anu, et al.
Publicado: (2020) -
The Nose as a Route for Therapy: Part 1. Pharmacotherapy
por: Cingi, Cemal, et al.
Publicado: (2021)